Morbidity and cost burden of methicillin-resistant Staphylococcus aureus in early onset ventilator-associated pneumonia

Critical Care

Volumn 10, Issue 3, 2006, Pages

  Shorr, Andrew F ^a   Tabak, Ying P ^b   Gupta, Vikas ^b   Johannes, R S ^b   Liu, Larry Z ^c   Kollef, Marin H ^d  

^a WASHINGTON HOSPITAL CENTER   (United States)

^b CARDINAL HEALTH   (United States)

^c PFIZER INC   (United States)

^d WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; ARTIFICIAL VENTILATION; BACTERIUM CULTURE; CONFIDENCE INTERVAL; CONTROLLED STUDY; COST OF ILLNESS; COVARIANCE; DISEASE SEVERITY; ECONOMIC EVALUATION; FEMALE; GRAM NEGATIVE BACTERIUM; HOSPITAL COST; HUMAN; INTENSIVE CARE UNIT; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MORBIDITY; MORTALITY; ONSET AGE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SAMPLE SIZE; STAPHYLOCOCCUS AUREUS; TREATMENT DURATION; VENTILATOR ASSOCIATED PNEUMONIA; ADVERSE EFFECTS; CLINICAL TRIAL; COHORT ANALYSIS; COMPARATIVE STUDY; DRUG EFFECTS; ECONOMICS; FACTUAL DATABASE; MEDICAL DEVICE CONTAMINATION; MIDDLE AGED; MULTICENTER STUDY; PENICILLIN RESISTANCE; PNEUMONIA, STAPHYLOCOCCAL; TIME FACTOR; VERY ELDERLY;

AGED; AGED, 80 AND OVER; COHORT STUDIES; DATABASES, FACTUAL; EQUIPMENT CONTAMINATION; FEMALE; HOSPITAL COSTS; HUMANS; MALE; METHICILLIN RESISTANCE; MIDDLE AGED; PNEUMONIA, STAPHYLOCOCCAL; RESPIRATION, ARTIFICIAL; RETROSPECTIVE STUDIES; STAPHYLOCOCCUS AUREUS; TIME FACTORS;

EID: 34447623956     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc4934     Document Type: Article

References (26)

1. Safdar N Dezfulian C Collard HR Saint S Clinical and economic consequences of ventilator-associated pneumonia: A systematic review Crit Care Med 2005 33 2184-2193 10.1097/01.CCM.0000181731.53912.D9 16215368
2. Heyland DK Cook DJ Griffith L Keenan SP Brun-Buisson C The attributable morbidity and mortality of ventilator-associated pneumonia in the critically ill patient. The Canadian Critical Trials Group Am J Respir Crit Care Med 1999 159 1249-1256 10194173
3. Rello J Ollendorf DA Oster G Vera-Llonch M Bellm L Redman R Kollef MH Epidemiology and outcomes of ventilator-associated pneumonia in a large US database Chest 2002 122 2115-2121 10.1378/chest.122.6.2115 12475855
4. Warren DK Shukla SJ Olsen MA Kollef MH Hollenbeak CS Cox MJ Cohen MM Fraser VJ Outcome and attributable cost of ventilator-associated pneumonia among intensive care unit patients in a suburban medical center Crit Care Med 2003 31 1312-1317 10.1097/ 01.CCM.0000063087.93157.06 12771596
5. Hugonnet S Eggimann P Borst F Maricot P Chevrolet JC Pittet D Impact of ventilator-associated pneumonia on resource utilization and patient outcome Infect Control Hosp Epidemiol 2004 25 1090-1096 10.1086/502349 15636298
6. Chastre J Fagon J-Y Ventilator-associated pneumonia Am J Respir Crit Care Med 2002 165 867-903 11934711
7. Kollef MH Shorr A Tabak YP Gupta V Liu LZ Johannes RS Epidemiology and outcomes of healthcare-associated pneumonia. Results from a large US database of culture-positive pneumonia Chest 2005 128 3854-3862 10.1378/ chest.128.6.3854 16354854
8. Fridkin SK Hill HA Volkova NV Edwards JR Lawton RM Gaynes RP McGowan JE Temporal changes in prevalence of antimicrobial resistance in 23 US hospitals Emerg Infect Dis 2002 8 697-701 12095437
9. Cosgrove SE Sakoulas G Perencevich EN Schwaber MJ Karchmer AW Carmeli Y Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: A meta-analysis Clin Infect Dis 2003 36 53-59 10.1086/345476 12491202
10. Zahar J-R Clec'h C Tafflet M Garrouste-Orgeas M Jamali S Mourvillier B Lassence AD Descorps-Declere A Adrie C Costa de Beauregard M-A Is methicillin resistance associated with a worse prognosis in Staphylococcus aureus ventilator-associated pneumonia? Clin Infect Dis 2005 41 1224-1231 10.1086/496923 16206094
11. Combes A Luyt CE Fagon JY Wollf M Trouillet JL Gibert C Chastre J Impact of methicillin resistance on outcome of Staphylococcus aureus ventilator-associated pneumonia Am J Respir Crit Care Med 2004 170 786-792 10.1164/rccm.200403-346OC 15242840
12. Ewig S Torres A Prevention and management of ventilator-associated pneumonia Curr Opin Crit Care 2002 8 58-69 10.1097/ 00075198-200202000-00010 12205408
13. Cosgrove SE Qi Y Kaye KS Harbarth S Karchmer AW Carmeli Y The impact of methicillin resistance in Staphylococcus aureus bacteremia on patient outcomes: Mortality, length of stay, and hospital charges Infect Control Hosp Epidemiol 2005 26 166-174 10.1086/502522 15756888
14. Abramson MA Sexton DJ Nosocomial methicillin-resistant and methicillin-susceptible Staphylococcus aureus primary bacteremia: At what costs? Infect Control Hosp Epidemiol 1999 20 408-411 10.1086/501641 10395142
15. Engemann JJ Carmeli Y Cosgrove SE Fowler VG Bronstein MZ Trivette SL Briggs JP Sexton DJ Kaye KS Adverse clinical and economic outcomes attributable to methicillin resistance among patients with Staphylococcus aureus surgical site infection Clin Infect Dis 2003 36 592-598 10.1086/367653 12594640
16. Acute Inpatient Files for Download http://www.cms.hhs.gov/ AcuteInpatientPPS/FFD/list.asp#TopOfPage
17. Iezzoni LI Ash AS Coffman GA Moskowitz MA Admission and mid-stay MedisGroups scores as predictors of hospitalization charges Med Care 1991 29 210-220 10.1097/00005650-199103000-00003 1900091
18. Iezzoni LI Moskowitz MA A clinical assessment of MedisGroups JAMA 1988 260 3159-3163 10.1001/jama.260.21.3159 3184394
19. Silber JH Rosenbaum PR Schwartz JS Ross RN Williams SV Evaluation of the complication rate as a measure of quality of care in coronary artery bypass graft surgery JAMA 1995 274 317-323 10.1001/jama.274.4.317 7609261
20. Fine MJ Auble TE Yealy DM Hanusa BH Weissfeld LA Singer DE Coley CM Marrie TJ Kapoor WN A prediction rule to identify low-risk patients with community-acquired pneumonia N Engl J Med 1997 336 243-250 10.1056/ NEJM199701233360402 8995086
21. Noskin GA Rubin RJ Schentag JJ Kluytmans J Hedblom EC Smulders M Lapetina E Gemmen E The burden of Staphylococcus aureus infections on hospitals in the United States. An analysis of the 2000 and 2001 Nationwide Inpatient Sample Database Arch Intern Med 2005 165 1756-1761 10.1001/archinte.165.15.1756 16087824
22. Shorr AF Combes A Kollef MH Chastre J Methicillin resistant Staphylococcus aureus prolongs intensive care unit length of stay in ventilator-associated pneumonia despite initially appropriate antibiotic therapy Crit Care Med 2006 34 700-706 10.1097/01.CCM.0000201885.57697.21 16505656
23. Olson ME Harmon BG Kollef MH Silver-coated endotracheal tubes associated with reduced bacterial burden in the lungs of mechanically ventilated dogs Chest 2002 121 863-870 10.1378/chest.121.3.863 11888974
24. Kokai-Kun JF Walsh SM Chanturiya T Mond JJ Lysostaphin cream eradicates Staphylococcus aureus nasal colonization in a cotton rat model Antimicrob Agents Chemother 2003 47 1589-1597 153340 12709327 10.1128/ AAC.47.5.1589-1597.2003
25. Muto CA Jernigan JA Ostrowsky BE Richet HM Jarvis WR Boyce JM Farr M SHEA guideline for preventing nosocomial transmission of multidrug-resistant strains of Staphylococcus aureus and enterococcus Infect Control Hosp Epidemiol 2003 24 362-386 10.1086/502213 12785411
26. Puzniak LA Leet T Mayfield J Kollef MH Mundy LM To gown or not to gown: the effect on acquisition of vancomycin resistant enterococci Clin Infect Dis 2002 35 18-25 10.1086/340739 12060870